GNH USA

Europe — EMA

Montelukast Aurobindo Pharma Italia

GNH USA supplies Montelukast Aurobindo Pharma Italia (Montelukast), a leukotriene receptor antagonist for asthma, allergic rhinitis and exercise‑induced

Montelukast

Request sourcing

1
Pack/s

What is Montelukast?

Montelukast, the active ingredient in Montelukast Aurobindo Pharma Italia, is a leukotriene receptor antagonist presented as an oral tablet for oral use. It treats asthma, allergic rhinitis and exercise‑induced bronchoconstriction in adults and children.

GNH USA supplies Montelukast Aurobindo Pharma Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Montelukast used for?

Montelukast acts on the leukotriene pathway to control inflammatory airway conditions.

Asthma: improves long‑term control and reduces exacerbations. Allergic rhinitis: relieves nasal congestion, sneezing and itching. Exercise‑induced bronchoconstriction: prevents airway narrowing triggered by physical activity.

What are the side effects of Montelukast?

Montelukast is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Abdominal pain: occasional discomfort. - Cough: transient irritation. - Dyspepsia: indigestion or upset stomach. - Nasopharyngitis: upper‑respiratory tract infection symptoms. - Dizziness: occasional light‑headedness.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips or throat. - Stevens‑Johnson syndrome: severe skin reactions. - Eosinophilic granulomatosis with polyangiitis: rare vasculitis. - Hepatic injury: elevated liver enzymes. - Anaphylaxis: life‑threatening allergic response. - Neuropsychiatric events: mood changes, suicidal thoughts.

What precautions apply to Montelukast?

Before initiating therapy, consider the following safety measures.

Pregnancy: consult a healthcare provider; use only if benefit outweighs risk. Breastfeeding: discuss potential exposure with a physician. Liver impairment: dose adjustment may be required. Neuropsychiatric monitoring: observe for mood changes or suicidal ideation. Store at ambient temperature: keep in the original pack, protect from moisture.

What does Montelukast interact with?

Montelukast may interact with several medicines; review concomitant therapy.

Major Interactions (Avoid): - Ritonavir: may increase montelukast plasma levels. - Phenobarbital: may reduce montelukast exposure. - Carbamazepine: may lower montelukast concentrations.

Moderate Interactions (Monitor Closely): - Fluconazole: may moderately increase exposure. - Erythromycin: may moderately increase exposure. - Warfarin: potential effect on INR, monitor coagulation.

Frequently asked questions

What is Montelukast Aurobindo Pharma Italia used for?+
Montelukast Aurobindo Pharma Italia is a leukotriene receptor antagonist indicated for the maintenance treatment of asthma, relief of symptoms of allergic rhinitis, and prevention of exercise‑induced bronchoconstriction in patients who require chronic therapy.
How does Montelukast work?+
Montelukast selectively blocks the cysteinyl leukotriene receptor CysLT1, preventing leukotriene D4 from triggering bronchoconstriction, airway edema, and inflammatory cell recruitment. This results in reduced airway narrowing and inflammation.
What is the usual dose of Montelukast?+
The prescribed dose of Montelukast is determined by the treating clinician based on the patient’s age, weight, and specific condition. Typical regimens involve once‑daily oral administration, but exact dosing must be set by a qualified healthcare professional.
Is Montelukast safe during pregnancy or breastfeeding?+
Safety data for Montelukast in pregnancy are limited, and the pregnancy category is listed as unknown. It should be used only if the potential benefit justifies any potential risk to the fetus. Breastfeeding mothers should discuss possible exposure with their physician.
How do I order Montelukast Aurobindo Pharma Italia from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Montelukast compare with inhaled corticosteroids?+
Montelukast targets leukotriene‑mediated inflammation, whereas inhaled corticosteroids act broadly on airway inflammation. Montelukast is often used as an add‑on therapy for patients whose asthma is not fully controlled with inhaled steroids, but it is not a substitute for rescue bronchodilators.
How should Montelukast Aurobindo Pharma Italia be stored and handled?+
Store the tablets at ambient temperature below 25 °C, in the original container, and protect them from moisture and direct sunlight. Keep out of reach of children and do not use after the expiry date.
How is Montelukast administered?+
Montelukast is taken orally as a tablet, swallowed whole with water. It may be taken with or without food, and the same time each day is recommended to maintain steady plasma levels.
What are the most serious risks associated with Montelukast?+
Serious but rare risks include angioedema, severe skin reactions such as Stevens‑Johnson syndrome, eosinophilic granulomatosis with polyangiitis, hepatic injury, anaphylaxis, and neuropsychiatric events like mood changes or suicidal thoughts. Prompt medical attention is required if any of these occur.
Who should not use Montelukast?+
Montelukast should be avoided in individuals with known hypersensitivity to montelukast or any of its excipients. Caution is advised for patients with severe liver disease, and it is not intended for the acute relief of bronchospasm during an asthma attack.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Montelukast
Route
Oral Use
Manufacturer
Aurobindo Pharma (Italia) S.R.L.
Origin
EU

Related products

MONTELUKAST SODIUM 5 mg/1

MONTELUKAST SODIUM 5 mg/1

Montelukast · 5 mg

Montelukast Sodium
TABLET, CHEWABLE
Ajanta Pharma USA Inc.
USA
MONTELUKAST SODIUM 5 mg/1

MONTELUKAST SODIUM 5 mg/1

Montelukast · 5 mg

Montelukast Sodium
TABLET, CHEWABLE
Ajanta Pharma USA Inc.
USA
Montelukast 10 mg/1

Montelukast 10 mg/1

Montelukast · 10 mg

Montelukast
TABLET
Macleods Pharmaceuticals Limited
USA
Montelukast 10 mg/1

Montelukast 10 mg/1

Montelukast · 10 mg

Montelukast
TABLET
Macleods Pharmaceuticals Limited
USA